BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Pseudomonas infection
,
Hippocampus
,
Nosology
,
Rosiglitazone
,
rs4950928
,
MYC
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
H3K27me3
Summary
General Info
Curated Studies
Most Correlated Studies
Induced Cdx2 binding progenitor motor neurons and its effect on H3K27me3 chromatin domains
Embryonic stem cells with H3F3A shRNA and H3F3B knockout
Fibroblasts, iPCs from fibroblasts and embryonic stem cells gene profiling
Leukemic CUTLL1 and CEM T-lymphocytes with JMJD3 and UTX shRNA knockdown
Leukemic CUTLL1 T-lymphocytes treated with 2uM of GSKJ4 for 24, 48, and 72 hours
Explore Curated Studies Results
Literature
Most Relevant Literature
Loss of H3K27me3 in meningiomas.
Low H3K27me3 deposition at CYP82E4 determines the nicotinic conversion rate in Nicotiana tabacum.
The Role of H3K27me3-Mediated Th17 Differentiation in Ankylosing Spondylitis.
Loss of H3K27me3 in WHO grade 3 meningioma.
There is another: H3K27me3-mediated genomic imprinting.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Acupuncture to Reduce Signs of Inflammation in Participants With Chronic Low Back Pain
A Study Evaluating CPI-1205 in Patients With B-Cell Lymphomas
A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK28…
Testing the Addition of an Anti-cancer Drug, Navtemadlin, to the Usual Treatments (Cytarabine and Id…
Testing the Addition of Tazemetostat to the Immunotherapy Drug, Pembrolizumab (MK-3475), in Advanced…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ